Answers are grounded in this paper and cite their sources.
Guidelines on biliary strictures highlight varying therapeutic strategies and cost-effectiveness, suggesting the need for tailored clinician approaches.
Although founded on similar evidence, guideline variations reflect differing risk tolerance and resource considerations. Clinicians must recognize these nuances to tailor management. Future research should clarify EUS seeding risk, evaluate cost-effectiveness, and inform harmonized guideline updates.
No takes yet. Share an insight, caveat, or question.
Gadour et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: